Clinical Trial Update: Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fluorouracil, oxaliplatin, and leucovorin in patients with metastatic gastric cancer or gastroesophageal junction cancer; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-10-18